Tareen Dermatology is pleased to announce that it will be conducting advanced-stage clinical studies for a novel experimental treatment for vitiligo in collaboration with CLINUVEL, a prestigious pharmaceutical company.
From this partnership, they seek to discover a novel medicine that will revolutionize the way vitiligo is treated and give hope to individuals dealing with this difficult skin condition.
People of various ages and ethnicities can get vitiligo, a chronic skin illness that results in areas of skin color loss. Treatment options for vitiligo, which affects around 1 in 100 persons, have been few and frequently ineffective.
Read also- Saravanan Krishnan has been Appointed by Dell Technologies as the New Country manager for Malaysia
Tareen Dermatology is dedicated to developing research and investigating novel approaches for the treatment of vitiligo through its relationship with CLINUVEL.
“We are excited to join forces with CLINUVEL in the pursuit of a breakthrough treatment for vitiligo,” said Dr. Mohiba Tareen, founder of Tareen Dermatology. “Our team is dedicated to providing cutting-edge care to our patients, and participating in these clinical trials is a testament to our commitment to improving the lives of those affected by vitiligo.”
Leading pharmaceutical business CLINUVEL is renowned for its proficiency in creating cutting-edge treatments for ailments affecting the brain and skin.
Read also- Hong Kong-Based Digital Art Fair has Partnered with LG Electronics
The new vitiligo treatment will be tested in clinical trials in association with Tareen Dermatology to assess its safety and effectiveness. The final goal is to receive regulatory authority for the treatment.
“We are thrilled to partner with Tareen Dermatology in this important research endeavor,” said Dr. Linda Teng, Director of North American Operations at CLINUVEL. “Tareen Dermatology possesses the expertise on pigmentation disorders and has access to populations affected by vitiligo. We continue to expand our efforts to bring a groundbreaking treatment to individuals with generalized vitiligo, offering them a renewed sense of confidence and well-being.”
About CLINUVEL
Clinuvel Pharmaceuticals is a global, diversified biopharmaceutical business that develops and commercializes therapies for genetic, metabolic, and life-threatening illnesses and general healthcare. Photomedicine and light-human biology pioneers.
About Tareen Dermatology
Tareen Dermatology is a premier dermatology center that treats patients with diverse skin diseases with compassion. A board-certified dermatologist with a love for dermatological research, Dr. Tareen runs the practice, which customizes services for each patient.
